Incidence and Factors Associated with Chloroquine Maculopathy in Patients Treated at Lamphun Hospital
Keywords:
อุบัติการณ์, ภาวะจุดรับภาพเสื่อม, ยาคลอโรควิน, ปัจจัยเสี่ยงAbstract
This retrospective case-control study aimed to determine an incidence and factors associated with chloroquine maculopathy in patients treated at Lamphun Hospital. The data was retrospectively collected and recorded including age, gender, indication for the use of chloroquine, cumulative dose, duration of chloroquine treatment, eye symptoms and eye examination findings. The diagnosis of chloroquine maculopathy was defined as perifoveal depigmentation or bull’s eye maculopathy. The data was analyzed by descriptive statistics, Chi-square test, Fisher’s Exact test, t-test and Odds ratio. Of the outpatients treated at the Eye Department of Lamphun hospital during 1st January 2011 – 31st December 2014, 83 were referred for chloroquine maculopathy evaluation. Among the 83 patients, 46 patients (55.4%) were diagnosed with chloroquine maculopathy. Factors significantly associated with chloroquine maculopathy were age (p=0.045 ), duration of chloroquine treatment ( p=0.028 ) and cumulative dose ( p=0.004 ) . In conclusion , regular eye examination are necessary and should be recommended to all patients taking chloroquine for early detection of chloroquine maculopathy and discontinue such medication to prevent further visual loss.
References
Bernstein H, Zvaifler N, Rubin M, Mansour AM. The ocular deposition of chloroquine. Invest Ophthalmol. 1963;2(4):384-92.
Cox NH, Paterson WD. Ocular toxicity of antimalarials in dermatology. Br J Dermatol 1994; 131(6):878-82.
Elman A, Gullberg R, Nisson E, Rendahl I, wachtmeister L. Chloroquine retinopathy in patients with rheumatoid arthritis. Scand J Rhematol. 1976;5(3):161-6.
Fishman GA, Sokol S. Toxic condition.In: Fishman GA, Sokol S. Electrophysiologic testing in disorders of retina, optic nerve and visual pathway. San Francisco: American Academy of ophthalmology.1990:60-1.
Henkind P, Rothfield NF. Ocular abnormalities in patients treated with synthetic antimalarial drugs. N Eng J Med. 1963;269(9):433-9.
Michael FM, Ulrich K, Timothy YY, Jonathan SL, William FM. Revised Recommendation on Screening for Chloroquine and Hydroxychloroquine Retinopathy. Ophthalmology. 2011;118(2):415-22.
Shinjo SK, O Maia Jr, VA Tizziani, Morita C, Kochen JA, WY Takahashi, et al. Chloroquine-induced bull’s eye maculopathy in rheumatoid arthritis: related to disease duration. Clin Rheumatol. 2007;26:1248-53.
Suansilpong A, Uaratanawong S. Accuracy of Amsler grid in screening for Chloroquine retinopathy. J Med Assoc Thai 2010;93(4)462-6.
Thongsiew S. Chloroquine Maculopathy in Chian Rai Regional Hospital. Lampang Med J 2010;31(3): 94-104.
Utumporn Srikua, Nipat Aui-aree. Timing of Chloroquine and Hydroxychloroquine screening. Thai J Ophthalmol 2008;22(1)61-68.

